首页 > 最新文献

Obesity Surgery最新文献

英文 中文
IFSO Bariatric Endoscopy Committee Evidence-Based Review and Position Statement on Endoscopic Sleeve Gastroplasty for Obesity Management. IFSO 减肥内镜委员会关于内镜袖状胃成形术治疗肥胖症的循证审查和立场声明。
IF 2.9 3区 医学 Q1 SURGERY Pub Date : 2024-11-01 DOI: 10.1007/s11695-024-07510-z
Barham K Abu Dayyeh, Christine Stier, Aayed Alqahtani, Reem Sharaiha, Mohit Bandhari, Silvana Perretta, Sigh Pichamol Jirapinyo, Gerhard Prager, Ricardo V Cohen
<p><strong>Background: </strong>Obesity is a significant global health issue. Metabolic and bariatric surgery (MBS) is the gold standard in the treatment of obesity due to its proven effectiveness and safety in the short and long term. However, MBS is not suitable for all patients. Some individuals are at high surgical risk or refuse surgical treatment, while others do not meet the criteria for MBS despite having obesity-related comorbidities. This gap has driven the development of endoscopic solutions like endoscopic sleeve gastroplasty (ESG), which offers a less invasive alternative that preserves organ function and reduces risks. A recent IFSO International Delphi consensus study highlighted that multidisciplinary experts agree on the utility of ESG for managing obesity in patients with class I and II obesity and for those with class III obesity who do not wish to pursue or qualify for MBS. This IFSO Bariatric Endoscopy Committee position statement aims to augment these consensus statements by providing a comprehensive systematic review of the evidence and delivering an evidence-based position on the value of ESG within the spectrum of obesity management.</p><p><strong>Methods: </strong>A comprehensive systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and Cochrane guidelines.</p><p><strong>Results: </strong>Systematic Review: The systematic review included 44 articles encompassing 15,714 patients receiving ESG. The studies varied from large case series to cohort studies and a randomized controlled trial (RCT). The mean baseline BMI was 37.56 kg/m2. The review focused on weight loss outcomes and safety data.</p><p><strong>Meta-analysis: </strong>Time point Mean %EWL Mean %TBWL 6 months 48.04 15.66 12 months 53.09 17.56 18 months 57.98 16.25 24 months 46.57 15.2 36 months 53.18 14.07 60 months 45.3 15.9 These results demonstrate significant weight loss following ESG.</p><p><strong>Safety: </strong>The pooled serious adverse event (SAE) rate was 1.25%. This low rate of SAEs indicates that ESG is a relatively safe procedure.</p><p><strong>Quality of evidence: </strong>The quality of evidence from the included observational studies was assessed as very low, primarily due to the inherent limitations associated with observational study designs, such as potential biases and lack of randomization. In contrast, the quality of evidence from the single randomized controlled trial was rated as MODERATE, reflecting a more robust study design that provides a higher level of evidence despite some limitations.</p><p><strong>Conclusions: </strong>The IFSO Bariatric Endoscopy Committee, after conducting a comprehensive systematic review and meta-analysis, endorses endoscopic sleeve gastroplasty (ESG) as an effective and valuable treatment for obesity. ESG is particularly beneficial for patients with class I and II obesity, as well as for those with class III obesity who are not suitable candidates for meta
背景:肥胖症是一个重大的全球健康问题。代谢和减肥手术(MBS)是治疗肥胖症的黄金标准,因为它在短期和长期内都被证明是有效和安全的。然而,代谢与减肥手术并不适合所有患者。有些人手术风险高或拒绝手术治疗,而另一些人尽管有肥胖相关的合并症,却不符合减重手术的标准。这种差距推动了内窥镜解决方案的发展,如内窥镜袖状胃成形术(ESG),它提供了一种创伤较小的替代方案,既能保留器官功能,又能降低风险。最近一项 IFSO 国际德尔菲共识研究强调,多学科专家一致认为 ESG 可用于控制 I 级和 II 级肥胖症患者的肥胖症,也可用于那些不希望或不符合 MBS 治疗条件的 III 级肥胖症患者。这份 IFSO 减肥内镜委员会立场声明旨在通过对证据进行全面系统的回顾,并就 ESG 在肥胖症管理范围内的价值提出基于证据的立场,从而加强这些共识声明:方法:按照系统综述和荟萃分析首选报告项目 (PRISMA) 和 Cochrane 指南进行全面系统综述:系统综述:系统综述包括 44 篇文章,涉及 15714 名接受 ESG 治疗的患者。这些研究既有大型病例系列研究,也有队列研究和随机对照试验(RCT)。平均基线体重指数为 37.56 kg/m2。综述重点关注减重结果和安全性数据:6 个月 48.04 15.66 12 个月 53.09 17.56 18 个月 57.98 16.25 24 个月 46.57 15.2 36 个月 53.18 14.07 60 个月 45.3 15.9 这些结果表明 ESG 治疗后体重明显减轻:严重不良事件(SAE)发生率为 1.25%。SAE发生率较低,表明ESG是一种相对安全的治疗方法:纳入的观察性研究的证据质量被评定为很低,这主要是由于观察性研究设计存在固有的局限性,如潜在的偏倚和缺乏随机化。相比之下,单项随机对照试验的证据质量被评为中度,反映出研究设计更加稳健,尽管存在一些局限性,但仍提供了较高水平的证据:IFSO减肥内镜委员会在进行了全面的系统回顾和荟萃分析后,认可内镜袖带胃成形术(ESG)是一种有效且有价值的肥胖症治疗方法。ESG 尤其适用于 I 级和 II 级肥胖症患者,以及不适合进行代谢减肥手术的 III 级肥胖症患者。ESG 的减肥效果显著,安全性良好,严重不良事件发生率低。尽管所纳入的观察性研究存在局限性,但分析中纳入的随机对照试验加强了 ESG 的有效性和安全性,为立场声明提供了循证基础。因此,IFSO 立场声明支持 ESG 在更广泛的肥胖管理中发挥作用,并为其提供了证据基础。
{"title":"IFSO Bariatric Endoscopy Committee Evidence-Based Review and Position Statement on Endoscopic Sleeve Gastroplasty for Obesity Management.","authors":"Barham K Abu Dayyeh, Christine Stier, Aayed Alqahtani, Reem Sharaiha, Mohit Bandhari, Silvana Perretta, Sigh Pichamol Jirapinyo, Gerhard Prager, Ricardo V Cohen","doi":"10.1007/s11695-024-07510-z","DOIUrl":"10.1007/s11695-024-07510-z","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Obesity is a significant global health issue. Metabolic and bariatric surgery (MBS) is the gold standard in the treatment of obesity due to its proven effectiveness and safety in the short and long term. However, MBS is not suitable for all patients. Some individuals are at high surgical risk or refuse surgical treatment, while others do not meet the criteria for MBS despite having obesity-related comorbidities. This gap has driven the development of endoscopic solutions like endoscopic sleeve gastroplasty (ESG), which offers a less invasive alternative that preserves organ function and reduces risks. A recent IFSO International Delphi consensus study highlighted that multidisciplinary experts agree on the utility of ESG for managing obesity in patients with class I and II obesity and for those with class III obesity who do not wish to pursue or qualify for MBS. This IFSO Bariatric Endoscopy Committee position statement aims to augment these consensus statements by providing a comprehensive systematic review of the evidence and delivering an evidence-based position on the value of ESG within the spectrum of obesity management.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A comprehensive systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and Cochrane guidelines.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Systematic Review: The systematic review included 44 articles encompassing 15,714 patients receiving ESG. The studies varied from large case series to cohort studies and a randomized controlled trial (RCT). The mean baseline BMI was 37.56 kg/m2. The review focused on weight loss outcomes and safety data.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Meta-analysis: &lt;/strong&gt;Time point Mean %EWL Mean %TBWL 6 months 48.04 15.66 12 months 53.09 17.56 18 months 57.98 16.25 24 months 46.57 15.2 36 months 53.18 14.07 60 months 45.3 15.9 These results demonstrate significant weight loss following ESG.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Safety: &lt;/strong&gt;The pooled serious adverse event (SAE) rate was 1.25%. This low rate of SAEs indicates that ESG is a relatively safe procedure.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Quality of evidence: &lt;/strong&gt;The quality of evidence from the included observational studies was assessed as very low, primarily due to the inherent limitations associated with observational study designs, such as potential biases and lack of randomization. In contrast, the quality of evidence from the single randomized controlled trial was rated as MODERATE, reflecting a more robust study design that provides a higher level of evidence despite some limitations.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The IFSO Bariatric Endoscopy Committee, after conducting a comprehensive systematic review and meta-analysis, endorses endoscopic sleeve gastroplasty (ESG) as an effective and valuable treatment for obesity. ESG is particularly beneficial for patients with class I and II obesity, as well as for those with class III obesity who are not suitable candidates for meta","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142558337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term Outcome of the Dutch Common Channel Trial (DUCATI): Preservation of Superior Weight Loss Results Without Significant Malnutrition Side Effects. 荷兰共同通道试验(DUCATI)的长期结果:保持了优异的减肥效果,且无明显的营养不良副作用。
IF 2.9 3区 医学 Q1 SURGERY Pub Date : 2024-11-01 Epub Date: 2024-10-02 DOI: 10.1007/s11695-024-07424-w
Ralph P M Gadiot, L Ulas Biter, Pierre G Feskens, Martin Dunkelgrun, Jan A Apers, Gerhard van 't Hof, Guido H H Mannaerts

Purpose: The optimal bowel limb lengths for laparoscopic Roux-en-Y gastric bypass (LRYGB) to maximize weight loss while minimizing nutritional deficiencies in severe obesity treatment remain a topic of debate. The multi-center Dutch Common Channel Trial (DUCATI) aims to compare the outcomes of a very long Roux Limb Roux-en-Y gastric bypass (VLRL-LRYGB) with a standard Roux-en-Y gastric bypass (S-LRYGB).

Methods: A total of 444 patients were randomly assigned in a 1:1, double-blind manner to undergo either VLRL-RYGB or S-LRYGB. Five-year follow-up data were assessed, concentrating on weight loss, obesity-related medical conditions, complications, re-operations, and malnutrition.

Results: Both groups had comparable total alimentary lengths (RL + CC). The VLRL-LRYGB group demonstrated significantly greater %TWL (32.2% vs. 28.6%, p = 0.002) and %EWL (81.2% vs. 70.3%, p = 0.002) at 5 years. Eight (3.6%) patients in the VLRL-LRYGB group versus 2 (0.9%) in the S-LRYGB group (p = 0.055) needed modification surgery for malabsorption. Suboptimal clinical response rate was significantly higher (22.0% vs. 8.3%) in S-LRYGB group. No significant differences for nutrient deficiencies in favor of the S-LRYGB group were found.

Conclusion: A 100-cm common channel with a relatively long Roux limb provides superior, sustainable weight loss over 5 years, without significantly increased rate of malabsorption-related re-operations. These results suggest that a longer Roux limb can still ensure adequate micronutrient uptake in the total alimentary tract. These findings should be considered in discussions regarding the optimal Roux-en-Y limb length for severe obesity treatment.

目的:腹腔镜鲁克斯-en-Y 胃旁路术(LRYGB)在治疗严重肥胖症时,如何最大限度地减轻体重,同时最大限度地减少营养不良,其最佳肠道肢体长度仍是一个争论不休的话题。多中心荷兰共同通道试验(DUCATI)旨在比较超长鲁克斯肢体鲁克斯-Y 胃旁路术(VLRL-LRYGB)与标准鲁克斯-Y 胃旁路术(S-LRYGB)的疗效:共有 444 名患者以 1:1 的双盲方式随机分配接受 VLRL-RYGB 或 S-LRYGB 胃旁路术。对五年的随访数据进行了评估,重点关注体重减轻、肥胖相关疾病、并发症、再次手术和营养不良等情况:结果:两组的消化道总长度(RL + CC)相当。5 年后,VLRL-LRYGB 组的体重减轻率(%TWL)(32.2% 对 28.6%,P = 0.002)和体重减轻率(%EWL)(81.2% 对 70.3%,P = 0.002)明显高于 VLRL-LRYGB 组。VLRL-LRYGB组有8例(3.6%)患者因吸收不良而需要进行改良手术,而S-LRYGB组只有2例(0.9%)(p = 0.055)。S-LRYGB组的次优临床反应率明显更高(22.0% vs. 8.3%)。在营养缺乏方面,S-LRYGB组与S-LRYGB组无明显差异:结论:100 厘米的共同通道和相对较长的鲁克斯肢体可在 5 年内提供卓越的、可持续的减肥效果,而与吸收不良相关的再手术率不会明显增加。这些结果表明,较长的鲁克斯肢体仍能确保整个消化道摄入足够的微量营养素。在讨论治疗重度肥胖症的最佳 Roux-en-Y 断肢长度时,应考虑这些研究结果。
{"title":"Long-term Outcome of the Dutch Common Channel Trial (DUCATI): Preservation of Superior Weight Loss Results Without Significant Malnutrition Side Effects.","authors":"Ralph P M Gadiot, L Ulas Biter, Pierre G Feskens, Martin Dunkelgrun, Jan A Apers, Gerhard van 't Hof, Guido H H Mannaerts","doi":"10.1007/s11695-024-07424-w","DOIUrl":"10.1007/s11695-024-07424-w","url":null,"abstract":"<p><strong>Purpose: </strong>The optimal bowel limb lengths for laparoscopic Roux-en-Y gastric bypass (LRYGB) to maximize weight loss while minimizing nutritional deficiencies in severe obesity treatment remain a topic of debate. The multi-center Dutch Common Channel Trial (DUCATI) aims to compare the outcomes of a very long Roux Limb Roux-en-Y gastric bypass (VLRL-LRYGB) with a standard Roux-en-Y gastric bypass (S-LRYGB).</p><p><strong>Methods: </strong>A total of 444 patients were randomly assigned in a 1:1, double-blind manner to undergo either VLRL-RYGB or S-LRYGB. Five-year follow-up data were assessed, concentrating on weight loss, obesity-related medical conditions, complications, re-operations, and malnutrition.</p><p><strong>Results: </strong>Both groups had comparable total alimentary lengths (RL + CC). The VLRL-LRYGB group demonstrated significantly greater %TWL (32.2% vs. 28.6%, p = 0.002) and %EWL (81.2% vs. 70.3%, p = 0.002) at 5 years. Eight (3.6%) patients in the VLRL-LRYGB group versus 2 (0.9%) in the S-LRYGB group (p = 0.055) needed modification surgery for malabsorption. Suboptimal clinical response rate was significantly higher (22.0% vs. 8.3%) in S-LRYGB group. No significant differences for nutrient deficiencies in favor of the S-LRYGB group were found.</p><p><strong>Conclusion: </strong>A 100-cm common channel with a relatively long Roux limb provides superior, sustainable weight loss over 5 years, without significantly increased rate of malabsorption-related re-operations. These results suggest that a longer Roux limb can still ensure adequate micronutrient uptake in the total alimentary tract. These findings should be considered in discussions regarding the optimal Roux-en-Y limb length for severe obesity treatment.</p>","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":"4136-4145"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142361799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastric Cancer in One-Anastomosis Mini-gastric Bypass: Case Report and Systematic Review. 单吻合口迷你胃旁路术中的胃癌:病例报告和系统回顾。
IF 2.9 3区 医学 Q1 SURGERY Pub Date : 2024-11-01 Epub Date: 2024-10-12 DOI: 10.1007/s11695-024-07545-2
Danilo Vinci, Antonio La Terra, Emilio Manno, Giovanni Merola, Andrea Muratore

In the last years, one-anastomosis gastric bypass (OAGB) has been proposed more frequently as obesity surgery technique. Several trials have demonstrated that the easier technical feasibility does not affect the long-term surgical result. However, concern about increased risk of gastric and esophageal cancers has been expressed by several bariatric surgeons. The present study reports the 2nd case of cancer of the gastrointestinal-jejunal anastomosis in a OAGB patient focusing the attention on some technical issues correlated and offering a systematic review of the literature.

近年来,单吻合胃旁路术(OAGB)作为肥胖症手术技术被越来越多地提出。多项试验表明,技术上的简便可行并不会影响长期手术效果。然而,一些减肥外科医生对胃癌和食道癌风险的增加表示担忧。本研究报告了第二例 OAGB 患者胃肠空肠吻合处癌症的病例,重点关注了一些相关的技术问题,并对文献进行了系统回顾。
{"title":"Gastric Cancer in One-Anastomosis Mini-gastric Bypass: Case Report and Systematic Review.","authors":"Danilo Vinci, Antonio La Terra, Emilio Manno, Giovanni Merola, Andrea Muratore","doi":"10.1007/s11695-024-07545-2","DOIUrl":"10.1007/s11695-024-07545-2","url":null,"abstract":"<p><p>In the last years, one-anastomosis gastric bypass (OAGB) has been proposed more frequently as obesity surgery technique. Several trials have demonstrated that the easier technical feasibility does not affect the long-term surgical result. However, concern about increased risk of gastric and esophageal cancers has been expressed by several bariatric surgeons. The present study reports the 2nd case of cancer of the gastrointestinal-jejunal anastomosis in a OAGB patient focusing the attention on some technical issues correlated and offering a systematic review of the literature.</p>","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":"4267-4270"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Weight Loss and Attendance Outcomes Following Metabolic and Bariatric Surgery: An Evaluation of The Cleveland Clinic Behavioral Rating System. 代谢和减肥手术后的长期减肥和护理效果:克利夫兰诊所行为评级系统评估》。
IF 2.9 3区 医学 Q1 SURGERY Pub Date : 2024-11-01 Epub Date: 2024-10-10 DOI: 10.1007/s11695-024-07425-9
Anne Jacobs, Karlijn Vermeer, Anna N Slok, Ignace M C Janssen, Rob A E M Tollenaar, Valerie M Monpellier

Introduction: Interdisciplinary guidelines recommend preoperative psychological evaluation before metabolic and bariatric surgery (MBS). The Cleveland Clinic Behavioral Rating System (CCBRS) has been developed to evaluate the psychological state of individuals undergoing MBS. However, its predictive value concerning long-term weight loss and follow-up attendance has not been extensively studied. This study aims to assess the predictive value of the CCBRS regarding weight loss and follow-up attendance up to 5 years after MBS.

Methods: In this cohort study (n = 1236), psychologists administered the CCBRS to each patient prior to MBS in addition to the standard psychosocial-behavioral screening. The CCBRS consists of nine psychological domains and is scored on a five-point Likert scale, from "poor" to "excellent." Linear mixed models and ordinal regression analysis were used to analyze the percentage total weight loss over time and follow-up attendance up to 5 years after surgery.

Results: A total of 1086 patients underwent subsequent MBS. Significant differences in weight loss and follow-up attendance were observed between some CCBRS groups compared to the reference group "excellent." However, these differences were not consistent across all groups within any given domain.

Conclusion: In this cohort, the predictive value of the CCBRS for weight loss and follow-up attendance up to 5 years after MBS was limited. It is important to consider certain limitations, such as considerable loss to follow-up. Nevertheless, the CCBRS remains valuable for structured psychological assessments by helping to identify patients' strengths and areas needing improvement.

简介跨学科指南建议在代谢和减肥手术(MBS)前进行术前心理评估。克利夫兰诊所行为评级系统(CCBRS)已被开发出来,用于评估接受代谢减重手术者的心理状态。然而,该系统对长期体重减轻和随访出席率的预测价值尚未得到广泛研究。本研究旨在评估CCBRS对MBS术后5年内体重减轻和随访出席率的预测价值:在这项队列研究中(n = 1236),除了标准的社会心理行为筛查外,心理学家还在 MBS 前对每位患者进行了 CCBRS 筛查。CCBRS 包括九个心理领域,采用李克特五点量表评分,从 "差 "到 "优"。研究人员采用线性混合模型和序数回归分析法来分析随时间推移体重减轻的百分比以及术后5年的随访情况:结果:共有 1086 名患者接受了后续的 MBS 治疗。与参照组 "优秀 "相比,CCBRS 的某些组别在体重减轻和随访出席率方面存在显著差异。然而,这些差异在任何特定领域的所有组别中都不一致:在该队列中,CCBRS对MBS后5年内体重减轻和随访出席率的预测价值有限。重要的是要考虑到某些局限性,如大量的随访损失。尽管如此,CCBRS仍有助于确定患者的优势和需要改进的方面,对结构化心理评估很有价值。
{"title":"Long-Term Weight Loss and Attendance Outcomes Following Metabolic and Bariatric Surgery: An Evaluation of The Cleveland Clinic Behavioral Rating System.","authors":"Anne Jacobs, Karlijn Vermeer, Anna N Slok, Ignace M C Janssen, Rob A E M Tollenaar, Valerie M Monpellier","doi":"10.1007/s11695-024-07425-9","DOIUrl":"10.1007/s11695-024-07425-9","url":null,"abstract":"<p><strong>Introduction: </strong>Interdisciplinary guidelines recommend preoperative psychological evaluation before metabolic and bariatric surgery (MBS). The Cleveland Clinic Behavioral Rating System (CCBRS) has been developed to evaluate the psychological state of individuals undergoing MBS. However, its predictive value concerning long-term weight loss and follow-up attendance has not been extensively studied. This study aims to assess the predictive value of the CCBRS regarding weight loss and follow-up attendance up to 5 years after MBS.</p><p><strong>Methods: </strong>In this cohort study (n = 1236), psychologists administered the CCBRS to each patient prior to MBS in addition to the standard psychosocial-behavioral screening. The CCBRS consists of nine psychological domains and is scored on a five-point Likert scale, from \"poor\" to \"excellent.\" Linear mixed models and ordinal regression analysis were used to analyze the percentage total weight loss over time and follow-up attendance up to 5 years after surgery.</p><p><strong>Results: </strong>A total of 1086 patients underwent subsequent MBS. Significant differences in weight loss and follow-up attendance were observed between some CCBRS groups compared to the reference group \"excellent.\" However, these differences were not consistent across all groups within any given domain.</p><p><strong>Conclusion: </strong>In this cohort, the predictive value of the CCBRS for weight loss and follow-up attendance up to 5 years after MBS was limited. It is important to consider certain limitations, such as considerable loss to follow-up. Nevertheless, the CCBRS remains valuable for structured psychological assessments by helping to identify patients' strengths and areas needing improvement.</p>","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":"4166-4178"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11541249/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142400888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Buccal Acupuncture: a Potential Treatment for Postoperative Nausea and Vomiting in Patients Undergoing Metabolic and Bariatric Surgery. 颊针:代谢和减肥手术患者术后恶心和呕吐的潜在治疗方法。
IF 2.9 3区 医学 Q1 SURGERY Pub Date : 2024-11-01 Epub Date: 2024-09-24 DOI: 10.1007/s11695-024-07513-w
Kai-Jing Liu, Yanjun Chen, Wah Yang, Xue-Mei Peng
{"title":"Buccal Acupuncture: a Potential Treatment for Postoperative Nausea and Vomiting in Patients Undergoing Metabolic and Bariatric Surgery.","authors":"Kai-Jing Liu, Yanjun Chen, Wah Yang, Xue-Mei Peng","doi":"10.1007/s11695-024-07513-w","DOIUrl":"10.1007/s11695-024-07513-w","url":null,"abstract":"","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":"4275-4276"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142308241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extended Length of Stay After Bariatric Surgery in China: Advantage or Disadvantage? 中国减肥手术后住院时间延长:优势还是劣势?
IF 2.9 3区 医学 Q1 SURGERY Pub Date : 2024-11-01 Epub Date: 2024-10-16 DOI: 10.1007/s11695-024-07540-7
Jialiang Sun, Guangjun Zhang, Jiangfan Zhu
{"title":"Extended Length of Stay After Bariatric Surgery in China: Advantage or Disadvantage?","authors":"Jialiang Sun, Guangjun Zhang, Jiangfan Zhu","doi":"10.1007/s11695-024-07540-7","DOIUrl":"10.1007/s11695-024-07540-7","url":null,"abstract":"","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":"3941-3943"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MiniMizer Gastric Ring displacement at 31 weeks of gestation as a life-threatening complication. 妊娠 31 周时 MiniMizer 胃环移位是一种危及生命的并发症。
IF 2.9 3区 医学 Q1 SURGERY Pub Date : 2024-11-01 Epub Date: 2024-10-05 DOI: 10.1007/s11695-024-07521-w
Paulina Szymczak, Magdalena Emilia Grzybowska, Adam Grzeczka, Michał Szymański, Dariusz Grzegorz Wydra

This case report describes a pregnant woman who underwent a laparoscopic MiniMizer Gastric Ring procedure for clinically severe obesity only one month before conception. At 31 weeks of gestation, the patient as admitted to the hospital with postprandial vomiting and persistent left-sided colicky abdominal pain. Maternal abdominal MRI revealed an intestinal obstruction and elective surgery was recommended. Due to the considerable risk to the fetus, antenatal corticosteroids were immediately administered to promote lung maturation and magnesium sulfate was started for fetal neuroprotection. During an exploratory laparoscopy, significantly enlarged and ischemic intestinal loops were found, leading to the decision to perform an atraumatic "en caul" cesarean delivery. After a successful "en caul" delivery, the MiniMizer ring, which had dislodged downwards and led to mesenteric ischemia, was visualized. Intraoperative esophagogastroduodenoscopy revealed a 1cm defect in the stomach wall related to gastric ring, covered with purulent exudate. Further exploration, showed a herniation of the distal alimentary loop through the Petersen foramen. Successful management included ring removal and intestinal loop reduction from the Petersen's space, without evidence of strangulation, as confirmed with indocyanine green (ICG) angiography. The postoperative course was uneventful. Women with obesity who have undergone bariatric surgery should to be informed of the increased likelihood of becoming pregnant after treatment. It is advised to notify the patient of the importance of maintaining a sufficient interval between bariatric surgery and conception. Additionally reports from the literature on various complications during pregnancy after bariatric surgery are presented.

本病例报告描述了一名孕妇在受孕前一个月才因重度肥胖接受了腹腔镜 MiniMizer 胃环手术。妊娠 31 周时,患者因餐后呕吐和持续性左侧腹部绞痛入院。母体腹部核磁共振成像显示有肠梗阻,建议进行择期手术。由于胎儿面临巨大风险,产前立即使用皮质类固醇促进肺成熟,并开始使用硫酸镁保护胎儿神经。在探查性腹腔镜检查中,发现了明显增大和缺血的肠套叠,因此决定进行无创伤的 "环形 "剖宫产。在成功进行 "全麻 "分娩后,发现了向下脱落并导致肠系膜缺血的 MiniMizer 环。术中食管胃十二指肠镜检查显示,胃壁上有一个 1 厘米的缺损,与胃环有关,上面覆盖着脓性渗出物。进一步检查显示,远端消化道襻通过彼得森孔疝出。经吲哚菁绿(ICG)血管造影证实,成功的治疗包括切除胃环,并从彼得森间隙缩小肠套叠,没有发现绞窄的迹象。术后恢复顺利。应告知接受减肥手术的肥胖妇女,治疗后怀孕的可能性会增加。建议告知患者在减肥手术和怀孕之间保持足够间隔的重要性。此外,本文还介绍了有关减肥手术后怀孕期间各种并发症的文献报告。
{"title":"MiniMizer Gastric Ring displacement at 31 weeks of gestation as a life-threatening complication.","authors":"Paulina Szymczak, Magdalena Emilia Grzybowska, Adam Grzeczka, Michał Szymański, Dariusz Grzegorz Wydra","doi":"10.1007/s11695-024-07521-w","DOIUrl":"10.1007/s11695-024-07521-w","url":null,"abstract":"<p><p>This case report describes a pregnant woman who underwent a laparoscopic MiniMizer Gastric Ring procedure for clinically severe obesity only one month before conception. At 31 weeks of gestation, the patient as admitted to the hospital with postprandial vomiting and persistent left-sided colicky abdominal pain. Maternal abdominal MRI revealed an intestinal obstruction and elective surgery was recommended. Due to the considerable risk to the fetus, antenatal corticosteroids were immediately administered to promote lung maturation and magnesium sulfate was started for fetal neuroprotection. During an exploratory laparoscopy, significantly enlarged and ischemic intestinal loops were found, leading to the decision to perform an atraumatic \"en caul\" cesarean delivery. After a successful \"en caul\" delivery, the MiniMizer ring, which had dislodged downwards and led to mesenteric ischemia, was visualized. Intraoperative esophagogastroduodenoscopy revealed a 1cm defect in the stomach wall related to gastric ring, covered with purulent exudate. Further exploration, showed a herniation of the distal alimentary loop through the Petersen foramen. Successful management included ring removal and intestinal loop reduction from the Petersen's space, without evidence of strangulation, as confirmed with indocyanine green (ICG) angiography. The postoperative course was uneventful. Women with obesity who have undergone bariatric surgery should to be informed of the increased likelihood of becoming pregnant after treatment. It is advised to notify the patient of the importance of maintaining a sufficient interval between bariatric surgery and conception. Additionally reports from the literature on various complications during pregnancy after bariatric surgery are presented.</p>","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":"4263-4266"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11541374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142375773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Education in Bariatric/Metabolic Surgery: Findings from the Young-IFSO Survey. 减肥/代谢外科教育:Young-IFSO 调查的结果。
IF 2.9 3区 医学 Q1 SURGERY Pub Date : 2024-11-01 Epub Date: 2024-09-28 DOI: 10.1007/s11695-024-07514-9
Liqi Li, Yang Bai
{"title":"Education in Bariatric/Metabolic Surgery: Findings from the Young-IFSO Survey.","authors":"Liqi Li, Yang Bai","doi":"10.1007/s11695-024-07514-9","DOIUrl":"10.1007/s11695-024-07514-9","url":null,"abstract":"","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":"4277-4278"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142351087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor-Gastric Wall Necrosis and Perforation Following Argon Plasma Coagulation (APC) Coupled with Endoscopic Sleeve Gastroplasty (ESG) and Its Emergency Laparoscopic Surgical Management. 致编辑的信-氩等离子凝固(APC)联合内镜袖状胃成形术(ESG)后的胃壁坏死和穿孔及其紧急腹腔镜手术治疗。
IF 2.9 3区 医学 Q1 SURGERY Pub Date : 2024-11-01 Epub Date: 2024-10-10 DOI: 10.1007/s11695-024-07538-1
Christopher McGowan, Barham Abu Dayyeh, Vivek Kumbhari
{"title":"Letter to the Editor-Gastric Wall Necrosis and Perforation Following Argon Plasma Coagulation (APC) Coupled with Endoscopic Sleeve Gastroplasty (ESG) and Its Emergency Laparoscopic Surgical Management.","authors":"Christopher McGowan, Barham Abu Dayyeh, Vivek Kumbhari","doi":"10.1007/s11695-024-07538-1","DOIUrl":"10.1007/s11695-024-07538-1","url":null,"abstract":"","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":"4288-4289"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142400887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concerns and Limitations of Intrathoracic Sleeve Migration Following Laparoscopic Sleeve Gastrectomy with Gastropexy. 腹腔镜袖带胃切除术配合胃切除术后袖带胸腔内移位的关注点和局限性。
IF 2.9 3区 医学 Q1 SURGERY Pub Date : 2024-11-01 Epub Date: 2024-10-19 DOI: 10.1007/s11695-024-07550-5
Ahmed Abokhozima, Hassan El-Masry, Mohamed H Zidan
{"title":"Concerns and Limitations of Intrathoracic Sleeve Migration Following Laparoscopic Sleeve Gastrectomy with Gastropexy.","authors":"Ahmed Abokhozima, Hassan El-Masry, Mohamed H Zidan","doi":"10.1007/s11695-024-07550-5","DOIUrl":"10.1007/s11695-024-07550-5","url":null,"abstract":"","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":"4294-4295"},"PeriodicalIF":2.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142471230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Obesity Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1